Crude and adjusted HRs (95% CIs) for stroke in the nephrolithiasis and control groups
| Characteristics | HRs for stroke | |||
| Crude* | P value | Adjusted*† | P value | |
| Total participants (n=95 515) | ||||
| Nephrolithiasis | 1.19 (1.12 to 1.25) | <0.001‡ | 1.18 (1.11 to 1.24) | <0.001‡ |
| Control | 1.00 | 1.00 | ||
| Age <60 years, men (n=44 595) | ||||
| Nephrolithiasis | 1.23 (1.12 to 1.36) | <0.001‡ | 1.22 (1.11 to 1.35) | <0.001‡ |
| Control | 1.00 | 1.00 | ||
| Age <60 years, women (n=22 140) | ||||
| Nephrolithiasis | 1.32 (1.16 to 1.51) | <0.001‡ | 1.27 (1.11 to 1.44) | <0.001‡ |
| Control | 1.00 | 1.00 | ||
| Age ≥60 years, men (n=16 920) | ||||
| Nephrolithiasis | 1.03 (0.93 to 1.15) | 0.543 | 1.03 (0.92 to 1.14) | 0.614 |
| Control | 1.00 | 1.00 | ||
| Age ≥60 years, women (n=11 860) | ||||
| Nephrolithiasis | 1.23 (1.09 to 1.38) | 0.001‡ | 1.22 (1.08 to 1.37) | 0.001‡ |
| Control | 1.00 | 1.00 | ||
*Models stratified by age, sex, income and region of residence.
†Adjusted for obesity, smoking, alcohol consumption, fasting blood glucose, total cholesterol and Charlson Comorbidity Index scores.
‡Cox proportional hazards regression model, significance at p<0.05.